Plants of the genus Vitis: Phenolic compounds, anticancer properties and clinical relevance
- Authors
- Salehi, Bahare; Vlaisavljevic, Sanja; Adetunji, Charles Oluwaseun; Adetunji, Juliana Bunmi; Kregiel, Dorota; Antolak, Hubert; Pawlikowska, Ewelina; Uprety, Yadav; Mileski, Ksenija S.; Devkota, Hari Prasad; Sharifi-Rad, Javad; Das, Gitishree; Patra, Jayanta Kumar; Jugran, Arun Kumar; Segura-Carretero, Antonio; del Mar Contreras, Maria
- Issue Date
- Sep-2019
- Publisher
- ELSEVIER SCIENCE LONDON
- Keywords
- Anticancer; Phenolic compounds; Proanthocyanidinds; Resveratrol; Vitis
- Citation
- TRENDS IN FOOD SCIENCE & TECHNOLOGY, v.91, pp 362 - 379
- Pages
- 18
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- TRENDS IN FOOD SCIENCE & TECHNOLOGY
- Volume
- 91
- Start Page
- 362
- End Page
- 379
- URI
- https://scholarworks.dongguk.edu/handle/sw.dongguk/7733
- DOI
- 10.1016/j.tifs.2019.07.042
- ISSN
- 0924-2244
- Abstract
- Background: Vitis genus comprised about 70 species. Concerning its pharmacological properties, V. vinifera is the most studied one, but there are other species with interest. Scope and approach: Therefore, this review aims to provide an updated overview on bioactive phytochemicals present in food products (grapes and wine) of V. vinifera and other Vitis species, as well as in different underused bioresources (stem, leaves, seeds, wine pomace, etc.). Moreover, due to their promising perspectives in the field of anticancer drug discovery, this bioactivity has been covered as well as the contribution that Vitis phenolic compounds has. Findings and conclusions: Among the plant products reviewed, grape seed extracts was the most investigated at preclinical phase, hence exhibiting a promising potential as anticancer drugs. However, an evidence-based clinical efficacy is still lacking.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Science and Biotechnology > ETC > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.